$INFU
InfuSystem Holdings, Inc

2017 Q1 Form 10-Q Financial Statement

#000119312517170745 Filed on May 15, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 Q1
Revenue $17.65M $18.29M
YoY Change -3.5% 9.38%
Cost Of Revenue $4.536M $3.506M
YoY Change 29.38% 16.29%
Gross Profit $10.65M $12.56M
YoY Change -15.19% 3.87%
Gross Profit Margin 60.32% 68.64%
Selling, General & Admin $9.351M $9.484M
YoY Change -1.4% 8.86%
% of Gross Profit 87.81% 75.53%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.510M $1.010M
YoY Change 49.5% 910.0%
% of Gross Profit 14.18% 8.04%
Operating Expenses $12.62M $12.14M
YoY Change 3.91% 15.24%
Operating Profit -$1.969M $414.0K
YoY Change -575.6% -73.32%
Interest Expense $328.0K $305.0K
YoY Change 7.54% -54.61%
% of Operating Profit 73.67%
Other Income/Expense, Net -$365.0K -$285.0K
YoY Change 28.07% -87.34%
Pretax Income -$2.334M $129.0K
YoY Change -1909.3% -118.43%
Income Tax -$856.0K $88.00K
% Of Pretax Income 68.22%
Net Earnings -$1.478M $41.00K
YoY Change -3704.88% -109.88%
Net Earnings / Revenue -8.37% 0.22%
Basic Earnings Per Share -$0.07 $0.00
Diluted Earnings Per Share -$0.07 $0.00
COMMON SHARES
Basic Shares Outstanding 22.68M 22.55M shares
Diluted Shares Outstanding 22.68M 23.04M shares

Balance Sheet

Concept 2017 Q1 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $200.0K $600.0K
YoY Change -66.67% -81.25%
Cash & Equivalents $194.0K $569.0K
Short-Term Investments
Other Short-Term Assets $1.304M $1.087M
YoY Change 19.96% -3.72%
Inventory $2.135M $2.622M
Prepaid Expenses
Receivables $12.08M $15.36M
Other Receivables $0.00 $0.00
Total Short-Term Assets $15.71M $22.38M
YoY Change -29.79% 11.44%
LONG-TERM ASSETS
Property, Plant & Equipment $1.914M $2.308M
YoY Change -17.07% -6.06%
Goodwill
YoY Change
Intangibles $29.63M $31.83M
YoY Change -6.91% 23.14%
Long-Term Investments
YoY Change
Other Assets $171.0K $260.0K
YoY Change -34.23% 26.21%
Total Long-Term Assets $76.18M $77.78M
YoY Change -2.06% 15.43%
TOTAL ASSETS
Total Short-Term Assets $15.71M $22.38M
Total Long-Term Assets $76.18M $77.78M
Total Assets $91.89M $100.2M
YoY Change -8.26% 14.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.902M $8.014M
YoY Change -38.83% 49.32%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $30.37M $5.177M
YoY Change 486.61% -6.5%
Total Short-Term Liabilities $40.11M $15.65M
YoY Change 156.26% 19.85%
LONG-TERM LIABILITIES
Long-Term Debt $2.100M $32.43M
YoY Change -93.53% 15.5%
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $2.146M $32.43M
YoY Change -93.38% 15.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $40.11M $15.65M
Total Long-Term Liabilities $2.146M $32.43M
Total Liabilities $42.26M $48.09M
YoY Change -12.12% 16.88%
SHAREHOLDERS EQUITY
Retained Earnings -$42.40M -$39.47M
YoY Change 7.44% -10.54%
Common Stock $2.000K $2.000K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $49.63M $52.08M
YoY Change
Total Liabilities & Shareholders Equity $91.89M $100.2M
YoY Change -8.26% 14.52%

Cashflow Statement

Concept 2017 Q1 2016 Q1
OPERATING ACTIVITIES
Net Income -$1.478M $41.00K
YoY Change -3704.88% -109.88%
Depreciation, Depletion And Amortization $1.510M $1.010M
YoY Change 49.5% 910.0%
Cash From Operating Activities -$1.442M $340.0K
YoY Change -524.12% -124.46%
INVESTING ACTIVITIES
Capital Expenditures -$1.020M -$3.270M
YoY Change -68.81% -189.1%
Acquisitions
YoY Change
Other Investing Activities $1.530M $880.0K
YoY Change 73.86% -21.43%
Cash From Investing Activities $510.0K -$2.390M
YoY Change -121.34% -6.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $33.00K
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.272M 1.800M
YoY Change -226.22% -72.93%
NET CHANGE
Cash From Operating Activities -1.442M 340.0K
Cash From Investing Activities 510.0K -2.390M
Cash From Financing Activities -2.272M 1.800M
Net Change In Cash -3.204M -250.0K
YoY Change 1181.6% -109.23%
FREE CASH FLOW
Cash From Operating Activities -$1.442M $340.0K
Capital Expenditures -$1.020M -$3.270M
Free Cash Flow -$422.0K $3.610M
YoY Change -111.69% -171.34%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
22755705 shares
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
569000
CY2017Q1 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
1864000
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4199000
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22688164 shares
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22885824 shares
CY2017Q1 us-gaap Assets
Assets
91893000
CY2017Q1 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
312000
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
4769000
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
5202000
CY2017Q1 us-gaap Assets Current
AssetsCurrent
15712000
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2017Q1 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
0
CY2017Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5928000
CY2017Q1 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
4837000
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
194000
CY2017Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
16196000
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
4323000
CY2017Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12079000
CY2017Q1 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
10000
CY2017Q1 us-gaap Common Stock Value
CommonStockValue
2000
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
4152000
CY2017Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
4902000
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
5236000
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
3951000
CY2017Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
92036000
CY2017Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
0
CY2017Q1 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
230000
CY2017Q1 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
2715000
CY2017Q1 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
2122000
CY2017Q1 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
5067000
CY2017Q1 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
608000
CY2017Q1 us-gaap Capital Leases Future Minimum Payments Remainder Of Fiscal Year
CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear
2273000
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
3408000
CY2017Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
181000
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
178000
CY2017Q1 us-gaap Long Term Debt
LongTermDebt
30369000
CY2017Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
30369000
CY2017Q1 us-gaap Other Assets Current
OtherAssetsCurrent
1304000
CY2017Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2146000
CY2017Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
29633000
CY2017Q1 us-gaap Inventory Net
InventoryNet
2135000
CY2017Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2127000
CY2017Q1 us-gaap Liabilities
Liabilities
42259000
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
91893000
CY2017Q1 us-gaap Liabilities Current
LiabilitiesCurrent
40113000
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
938000
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
718000
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
562000
CY2017Q1 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
24000
CY2017Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
30369000
CY2017Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
171000
CY2017Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2017Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
53239000
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
831000
CY2017Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1914000
CY2017Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6113000
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
49634000
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-42404000
CY2017Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
129000
CY2017Q1 infu Unamortized Debt Issuance Expense Current
UnamortizedDebtIssuanceExpenseCurrent
129000
CY2017Q1 infu Capital And Operating Leases Future Minimum Payments Due Thereafter
CapitalAndOperatingLeasesFutureMinimumPaymentsDueThereafter
938000
CY2017Q1 infu Capital And Operating Leases Future Minimum Payments Due
CapitalAndOperatingLeasesFutureMinimumPaymentsDue
8475000
CY2017Q1 infu Medical Equipment Net
MedicalEquipmentNet
28267000
CY2017Q1 infu Accumulated Depreciation On Pump Equipment
AccumulatedDepreciationOnPumpEquipment
4400000
CY2017Q1 infu Capital And Operating Leases Future Minimum Payments Due In Four Years
CapitalAndOperatingLeasesFutureMinimumPaymentsDueInFourYears
490000
CY2017Q1 infu Capital And Operating Leases Future Minimum Payments Due In Three Years
CapitalAndOperatingLeasesFutureMinimumPaymentsDueInThreeYears
1170000
CY2017Q1 infu Medical Equipment In Rental Services Reserve
MedicalEquipmentInRentalServicesReserve
611000
CY2017Q1 infu Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
23606000
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6115000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1997000
CY2017Q1 infu Capital And Operating Leases Future Minimum Payments Due In Five Years
CapitalAndOperatingLeasesFutureMinimumPaymentsDueInFiveYears
191000
CY2017Q1 infu Medical Equipment In Rental Services Gross
MedicalEquipmentInRentalServicesGross
59049000
CY2017Q1 infu Medical Equipment Held For Sale Or Rental
MedicalEquipmentHeldForSaleOrRental
1371000
CY2017Q1 infu Medical Equipment In Rental Services Accumulated Depreciation
MedicalEquipmentInRentalServicesAccumulatedDepreciation
31542000
CY2017Q1 infu Medical Equipment In Rental Service Net Of Accumulated Depreciation
MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation
26896000
CY2017Q1 infu Capital And Operating Leases Future Minimum Payments Due In Two Years
CapitalAndOperatingLeasesFutureMinimumPaymentsDueInTwoYears
2695000
CY2017Q1 infu Unamortized Value Of Debt Issuance Costs Principal In Year Five
UnamortizedValueOfDebtIssuanceCostsPrincipalInYearFive
0
CY2017Q1 infu Unamortized Value Of Debt Issuance Costs Principal In Year Four
UnamortizedValueOfDebtIssuanceCostsPrincipalInYearFour
0
CY2017Q1 infu Unamortized Value Of Debt Issuance Costs Principal Remainder Of Fiscal Year
UnamortizedValueOfDebtIssuanceCostsPrincipalRemainderOfFiscalYear
129000
CY2017Q1 infu Unamortized Value Of Debt Issuance Costs Principal In Year Three
UnamortizedValueOfDebtIssuanceCostsPrincipalInYearThree
0
CY2017Q1 infu Unamortized Value Of Debt Issuance Costs Principal In Year Two
UnamortizedValueOfDebtIssuanceCostsPrincipalInYearTwo
0
CY2017Q1 infu Capital And Operating Leases Future Minimum Payments Remainder Of Fiscal Year
CapitalAndOperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
2991000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
818000
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4118000
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22669675 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22867335 shares
CY2016Q4 us-gaap Assets
Assets
96344000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
20769000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4989000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3398000
CY2016Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
12436000
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11581000
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5315000
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
91829000
CY2016Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
2675000
CY2016Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
2938000
CY2016Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
2573000
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2016Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
26577000
CY2016Q4 us-gaap Long Term Debt
LongTermDebt
31891000
CY2016Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
5314000
CY2016Q4 us-gaap Other Assets Current
OtherAssetsCurrent
949000
CY2016Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
29216000
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
31239000
CY2016Q4 us-gaap Inventory Net
InventoryNet
2166000
CY2016Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2872000
CY2016Q4 us-gaap Liabilities
Liabilities
45655000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
96344000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16439000
CY2016Q4 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
66000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
225000
CY2016Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
53438000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
50689000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-41142000
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
109000
CY2016Q4 infu Unamortized Debt Issuance Expense Current
UnamortizedDebtIssuanceExpenseCurrent
22000
CY2016Q4 infu Medical Equipment Net
MedicalEquipmentNet
29678000
CY2016Q4 infu Accumulated Depreciation On Pump Equipment
AccumulatedDepreciationOnPumpEquipment
3900000
CY2016Q4 infu Medical Equipment In Rental Services Reserve
MedicalEquipmentInRentalServicesReserve
551000
CY2016Q4 infu Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
22199000
CY2016Q4 infu Medical Equipment In Rental Services Gross
MedicalEquipmentInRentalServicesGross
59034000
CY2016Q4 infu Medical Equipment Held For Sale Or Rental
MedicalEquipmentHeldForSaleOrRental
1642000
CY2016Q4 infu Unamortized Debt Issuance Expense Noncurrent
UnamortizedDebtIssuanceExpenseNoncurrent
87000
CY2016Q4 infu Medical Equipment In Rental Services Accumulated Depreciation
MedicalEquipmentInRentalServicesAccumulatedDepreciation
30447000
CY2016Q4 infu Medical Equipment In Rental Service Net Of Accumulated Depreciation
MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation
28036000
CY2016 infu Pump Equipments Net
PumpEquipmentsNet
13900000
CY2017Q1 dei Entity Registrant Name
EntityRegistrantName
InfuSystem Holdings, Inc
CY2017Q1 dei Document Type
DocumentType
10-Q
CY2017Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001337013
CY2017Q1 dei Document Period End Date
DocumentPeriodEndDate
2017-03-31
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3204000
CY2017Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017Q1 dei Amendment Flag
AmendmentFlag
false
CY2017Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6465000
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2017Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2017Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2017Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1411000
CY2017Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
100000
CY2017Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.367 pure
CY2017Q1 us-gaap Sales Revenue Net
SalesRevenueNet
17654000
CY2017Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
200000
CY2017Q1 us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
4099000
CY2017Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-365000
CY2017Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-37000
CY2017Q1 us-gaap Gross Profit
GrossProfit
10649000
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
12618000
CY2017Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
87000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-1478000
CY2017Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1856000
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2334000
CY2017Q1 us-gaap Interest Expense
InterestExpense
328000
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
510000
CY2017Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
25000
CY2017Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2017Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1525000
CY2017Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
20000
CY2017Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1969000
CY2017Q1 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
15137000
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-2272000
CY2017Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
1015000
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-856000
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1442000
CY2017Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4536000
CY2017Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2517000
CY2017Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22680562 shares
CY2017Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22680562 shares
CY2017Q1 dei Trading Symbol
TradingSymbol
INFU
CY2017Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2886000
CY2017Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
6413000
CY2017Q1 infu Cost Of Revenues Pump Depreciation Sales And Disposals
CostOfRevenuesPumpDepreciationSalesAndDisposals
2469000
CY2017Q1 infu Leverage Ratio
LeverageRatio
2.96 pure
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-249000
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6669000
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2017Q1 infu Pump Equipments Net
PumpEquipmentsNet
14000000
CY2017Q1 infu Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
1600000
CY2016Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
912000
CY2016Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
100000
CY2016Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.682 pure
CY2016Q1 us-gaap Sales Revenue Net
SalesRevenueNet
18294000
CY2016Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
200000
CY2016Q1 us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
17081000
CY2016Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-285000
CY2016Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
20000
CY2016Q1 us-gaap Gross Profit
GrossProfit
12557000
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
12143000
CY2016Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
125000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
41000
CY2016Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1747000
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
129000
CY2016Q1 us-gaap Interest Expense
InterestExpense
305000
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2390000
CY2016Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
884000
CY2016Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
33000
CY2016Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
490718 shares
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
414000
CY2016Q1 infu Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
1500000
CY2016Q1 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
16488000
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1804000
CY2016Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
3274000
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
88000
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
337000
CY2016Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3506000
CY2016Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1806000
CY2016Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23039256 shares
CY2016Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22548538 shares
CY2016Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2815000
CY2016Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
15369000
CY2016Q1 infu Cost Of Revenues Pump Depreciation Sales And Disposals
CostOfRevenuesPumpDepreciationSalesAndDisposals
2231000

Files In Submission

Name View Source Status
0001193125-17-170745-index-headers.html Edgar Link pending
0001193125-17-170745-index.html Edgar Link pending
0001193125-17-170745.txt Edgar Link pending
0001193125-17-170745-xbrl.zip Edgar Link pending
d308476d10q.htm Edgar Link pending
d308476dex311.htm Edgar Link pending
d308476dex312.htm Edgar Link pending
d308476dex321.htm Edgar Link pending
d308476dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g308476txpg01.jpg Edgar Link pending
infu-20170331.xml Edgar Link completed
infu-20170331.xsd Edgar Link pending
infu-20170331_cal.xml Edgar Link unprocessable
infu-20170331_def.xml Edgar Link unprocessable
infu-20170331_lab.xml Edgar Link unprocessable
infu-20170331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending